SCOPUS 정보 검색 플랫폼

Volumn 76, Issue 15, 2002, Pages 7625-7631

Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines

(13) Amara, Rama Rao a Villinger, Francois a Staprans, Silvija I a Altman, John D a Montefiori, David C a Kozyr, Natalia L a Xu, Yan a Wyatt, Linda S a Earl, Patricia L a Herndon, James G a McClure, Harold M a Moss, Bernard a Robinson, Harriet L a

a NONE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; POL PROTEIN; RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA VACCINE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANTIGEN BINDING; ARTICLE; CHIMERA; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IMMUNIZATION; LEUKOCYTE COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS INFECTION;

AIDS VACCINES; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FUSION PROTEINS, GAG-POL; GENE PRODUCTS, ENV; HIV; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; MACACA MULATTA; RNA, VIRAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINES, DNA; VACCINIA VIRUS;

EID: 0036310296 PISSN: 0022538X EISSN: None Source Type: Journal
DOI: 10.1128/JVI.76.15.7625-7631.2002 Document Type: Article

Times cited : (137)

References (25)

1
- 18144441678
- Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen
- (2000) J. Immunol. , vol.164 , pp. 4968-4978
- Allen, T.M.¹ Vogel, T.U.² Fuller, D.H.³ Mothe, B.R.⁴ Steffen, S.⁵ Boyson, J.E.⁶ Shipley, T.⁷ Fuller, J.⁸ Hanke, T.⁹ Sette, A.¹⁰ Altman, J.D.¹¹ Moss, B.¹² McMichael, A.J.¹³ Watkins, D.I.¹⁴

2
- 0035815437
- Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
- (2001) Science , vol.292 , pp. 69-74
- Amara, R.R.¹ Villinger, F.² Altman, J.D.³ Lydy, S.L.⁴ O'Neil, S.P.⁵ Staprans, S.⁶ Montefiori, D.C.⁷ Xu, Y.⁸ Herndon, J.G.⁹ Wyatt, L.S.¹⁰ Candido, M.A.¹¹ Kozyr, N.L.¹² Earl, P.L.¹³ Smith, J.M.¹⁴ Ma, H.-L.¹⁵ Grimm, B.D.¹⁶ Hulsey, M.L.¹⁷ Miller, J.¹⁸ McClure, H.M.¹⁹ McNicholl, J.M.²⁰ Moss, B.²¹ Robinson, H.L.²² more..

3
- 0035025623
- Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination
- (2001) J. Virol. , vol.75 , pp. 5151-5158
- Barouch, D.H.¹ Santra, S.² Kuroda, M.J.³ Schmitz, J.E.⁴ Plishka, R.⁵ Buckler-White, A.⁶ Gaitan, A.E.⁷ Zin, R.⁸ Nam, J.H.⁹ Wyatt, L.S.¹⁰ Lifton, M.A.¹¹ Nickerson, C.E.¹² Moss, B.¹³ Montefiori, D.C.¹⁴ Hirsch, V.M.¹⁵ Letvin, N.L.¹⁶

4
- 0033766645
- Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
- (2000) Science , vol.290 , pp. 486-492
- Barouch, D.H.¹ Santra, S.² Schmitz, J.E.³ Kuroda, M.J.⁴ Fu, T.M.⁵ Wagner, W.⁶ Bilska, M.⁷ Craiu, A.⁸ Zheng, X.X.⁹ Krivulka, G.R.¹⁰ Beaudry, K.¹¹ Lifton, M.A.¹² Nickerson, C.E.¹³ Trigona, W.L.¹⁴ Punt, K.¹⁵ Freed, D.C.¹⁶ Guan, L.¹⁷ Dubey, S.¹⁸ Casimiro, D.¹⁹ Simon, A.²⁰ more..

5
- 18344405225
- mac251: Dependence on route of challenge exposure
- (1998) J. Virol. , vol.72 , pp. 4170-4182
- Benson, J.¹ Chougnet, C.² Robert-Guroff, M.³ Montefiori, D.⁴ Markham, P.⁵ Shearer, G.⁶ Gallo, R.C.⁷ Cranage, M.⁸ Paoletti, E.⁹ Limbach, K.¹⁰ Venzon, D.¹¹ Tartaglia, J.¹² Franchini, G.¹³

6
- 0031899907
- Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: Implications for use as a human vaccine
- (1998) J. Gen. Virol. , vol.79 , pp. 1159-1167
- Blanchard, T.J.¹ Alcami, A.² Andrea, P.³ Smith, G.L.⁴

7
- 0035793065
- + T cells: Implications for the development of therapeutic strategies
- (2001) Proc. Natl. Acad. Sci. USA , vol.98 , pp. 253-258
- Chun, T.W.¹ Justement, J.S.² Moir, S.³ Hallahan, C.W.⁴ Ehler, L.A.⁵ Liu, S.⁶ McLaughlin, M.⁷ Dybul, M.⁸ Mican, J.M.⁹ Fauci, A.S.¹⁰

8
- 0032990252
- Comparison of the immunogenicity and efficacy of a replication-defective vaccinia virus expressing antigens of human parainfluenza virus type 3 (HPIV3) with those of a live attenuated HPIV3 vaccine candidate in rhesus monkeys passively immunized with PIV3 antibodies
- (1999) J. Infect. Dis. , vol.179 , pp. 1345-1351
- Durbin, A.P.¹ Cho, C.J.² Elkins, W.R.³ Wyatt, L.S.⁴ Moss, B.⁵ Murphy, B.R.⁶

9
- 0030808980
- 4+ T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele
- (1997) J. Exp. Med. , vol.186 , pp. 455-460
- Furci, L.¹ Scarlatti, G.² Burastero, S.³ Tambussi, G.⁴ Colognesi, C.⁵ Quillent, C.⁶ Longhi, R.⁷ Loverro, P.⁸ Borgonovo, B.⁹ Gaffi, D.¹⁰ Carrow, E.¹¹ Malnati, M.¹² Lusso, P.¹³ Siccardi, A.G.¹⁴ Lazzarin, A.¹⁵ Beretta, A.¹⁶

10
- 0034284924
- Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: Comparison of one- versus two-enzyme systems
- (2000) AIDS Res. Hum. Retrovir. , vol.16 , pp. 1247-1257
- Hofmann-Lehmann, R.¹ Swenerton, R.K.² Liska, V.³ Leutenegger, C.M.⁴ Lutz, H.⁵ McClure, H.M.⁶ Ruprecht, R.M.⁷

11
- 0032850575
- +-T-cell response to human cytomegalovirus: The 72-kilodalton major immediate-early protein revisited
- (1999) J. Virol. , vol.73 , pp. 8179-8184
- Kern, F.¹ Surel, I.P.² Faulhaber, N.³ Frommel, C.⁴ Schneider-Mergener, J.⁵ Schönemann, C.⁶ Reinke, P.⁷ Volk, H.D.⁸

12
- 0031452947
- A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing
- (1997) Tissue Antigens , vol.50 , pp. 657-661
- Knapp, L.A.¹ Lehmann, E.² Piekarczyk, M.S.³ Urvater, J.A.⁴ Watkins, D.I.⁵

13
- 0028488883
- Experiences with immunization against orthopox viruses of humans and animals using vaccine strain MVA
- In German
- (1994) Berl. Muench. Tieraerztl. Wochenschr. , vol.107 , pp. 253-256
- Mahnel, H.¹ Mayr, A.²

14
- 0018246525
- The smallpox vaccination strain MVA: Marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defense mechanism
- In German
- (1978) Zentbl. Bakteriol. B , vol.167 , pp. 375-390
- Mayr, A.¹ Stickl, H.² Muller, H.K.³ Danner, K.⁴ Singer, H.⁵

15
- 0031901463
- Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1
- (1998) J. Virol. , vol.72 , pp. 3427-3431
- Montefiori, D.C.¹ Reimann, K.A.² Wyand, M.S.³ Manson, K.⁴ Lewis, M.G.⁵ Collman, R.G.⁶ Sodroski, J.G.⁷ Bolognesi, D.P.⁸ Letvin, N.L.⁹

16
- 0023907054
- Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay
- (1988) J. Clin. Microbiol. , vol.26 , pp. 231-235
- Montefiori, D.C.¹ Robinson W.E., Jr.² Schuffman, S.S.³ Mitchell, W.M.⁴

17
- 0033995525
- Recombinant modified vaccinia virus Ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques
- (2000) J. Virol. , vol.74 , pp. 2960-2965
- Ourmanov, I.¹ Bilska, M.² Hirsch, V.M.³ Montefiori, D.C.⁴

18
- 0034093217
- Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV
- (2000) J. Virol. , vol.74 , pp. 2740-2751
- Ourmanov, I.¹ Brown, C.R.² Moss, B.³ Carroll, M.⁴ Wyatt, L.⁵ Pletneva, L.⁶ Goldstein, S.⁷ Venzon, D.⁸ Hirsch, V.M.⁹

19
- 0004095784
- Springer, New York, N.Y.
- (2001) Mixed effects models in S and S-PLUS
- Pinheiro, J.C.¹ Bates, D.M.²

20
- 0032867812
- A valid ELISPOT assay for enumeration of ex vivo, antigenspecific, IFN-γ-producing T cells
- (1999) J. Immunol. Methods , vol.227 , pp. 99-107
- Power, C.A.¹ Grand, C.L.² Ismail, N.³ Peters, N.C.⁴ Yurkowski, D.P.⁵ Bretscher, P.A.⁶

21
- 0032920019
- Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunization
- (1999) Nat. Med. , vol.5 , pp. 526-534
- Robinson, H.L.¹ Montefiori, D.C.² Johnson, R.P.³ Manson, K.H.⁴ Kalish, M.L.⁵ Lifson, J.D.⁶ Rizvi, T.A.⁷ Lu, S.⁸ Hu, S.-L.⁹ Mazzara, G.P.¹⁰ Panicali, D.L.¹¹ Herndon, J.G.¹² Glickman, R.¹³ Candido, M.A.¹⁴ Lydy, S.L.¹⁵ Wyand, M.S.¹⁶ McClure, H.M.¹⁷

22
- 17944369239
- An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants
- (2001) Cell , vol.106 , pp. 539-549
- Rose, N.F.¹ Marx, P.A.² Luckay, A.³ Nixon, D.F.⁴ Moretto, W.J.⁵ Donahoe, S.M.⁶ Montefiori, D.⁷ Roberts, A.⁸ Buonocore, L.⁹ Rose, J.K.¹⁰

23
- 0032861392
- + T cells using heterologous prime-boost immunisation strategies
- (1999) Immunol. Rev. , vol.170 , pp. 29-38
- Schneider, J.¹ Gilbert, S.C.² Hannan, C.M.³ Degano, P.⁴ Sheu, E.G.⁵ Plebanski, M.⁶ Hill, A.V.S.⁷

24
- 0034002502
- Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies
- (2000) J. Virol. , vol.74 , pp. 4236-4243
- Stittelaar, K.J.¹ Wyatt, L.S.² De Swart, R.L.³ Vos, H.W.⁴ Groen, J.⁵ Van Amerongen, G.⁶ Van Binnendijk, R.S.⁷ Rozenblatt, S.⁸ Moss, B.⁹ Osterhaus, A.D.¹⁰

25
- 0026442276
- Nonreplicating vaccinia vector efficiently expresses recombinant genes
- (1992) Proc. Natl. Acad. Sci. USA , vol.89 , pp. 10847-10851
- Sutter, G.¹ Moss, B.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.